AU2003269949A1 - Substituted 1,4-pyrazine derivatives - Google Patents
Substituted 1,4-pyrazine derivativesInfo
- Publication number
- AU2003269949A1 AU2003269949A1 AU2003269949A AU2003269949A AU2003269949A1 AU 2003269949 A1 AU2003269949 A1 AU 2003269949A1 AU 2003269949 A AU2003269949 A AU 2003269949A AU 2003269949 A AU2003269949 A AU 2003269949A AU 2003269949 A1 AU2003269949 A1 AU 2003269949A1
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- pyrazine derivatives
- pyrazine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41026102P | 2002-09-12 | 2002-09-12 | |
| US60/410,261 | 2002-09-12 | ||
| PCT/US2003/024805 WO2004024719A1 (en) | 2002-09-12 | 2003-08-27 | Substituted 1,4-pyrazine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003269949A1 true AU2003269949A1 (en) | 2004-04-30 |
Family
ID=31994096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003269949A Abandoned AU2003269949A1 (en) | 2002-09-12 | 2003-08-27 | Substituted 1,4-pyrazine derivatives |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040116444A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1539736A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2006506350A (cg-RX-API-DMAC10.html) |
| AR (1) | AR041125A1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU2003269949A1 (cg-RX-API-DMAC10.html) |
| BR (1) | BR0314139A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2494975A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MXPA05002418A (cg-RX-API-DMAC10.html) |
| TW (1) | TW200503717A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2004024719A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05012082A (es) * | 2003-05-09 | 2006-02-22 | Pharmacia & Upjohn Co Llc | Compuestos como antagonistas del receptor crf1. |
| US20060211710A1 (en) * | 2005-03-17 | 2006-09-21 | Pfizer Inc | Substituted aryl 1,4-pyrazine derivatives |
| IL311645B2 (en) * | 2016-07-12 | 2025-11-01 | Revolution Medicines Inc | 2,5- disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines asallosteric shp2 inhibitors |
| CN110446709B (zh) | 2017-01-23 | 2023-09-12 | 锐新医药公司 | 作为变构shp2抑制剂的二环化合物 |
| CA3051054A1 (en) | 2017-01-23 | 2018-07-26 | Revolution Medicines, Inc. | Pyridine compounds as allosteric shp2 inhibitors |
| TWI852912B (zh) | 2017-09-07 | 2024-08-21 | 美商銳新醫藥公司 | Shp2抑制劑組合物以及治療癌症的方法 |
| BR112020007058A2 (pt) | 2017-10-12 | 2020-10-06 | Revolution Medicines, Inc. | compostos de piridina, pirazina, e triazina como inibidores de shp2 alostéricos |
| BR112020009757A2 (pt) | 2017-12-15 | 2020-11-03 | Revolution Medicines, Inc. | compostos policíclicos como inibidores alostéricos de shp2 |
| PL3788049T3 (pl) | 2018-05-01 | 2023-06-19 | Revolution Medicines, Inc. | Połączone z C40, C28 i C32 analogi rapamycyny jako inhibitory mTOR |
| EP3788050B1 (en) | 2018-05-01 | 2024-08-28 | Revolution Medicines, Inc. | C26-linked rapamycin analogs as mtor inhibitors |
| EP4531859A4 (en) | 2022-05-25 | 2026-05-27 | Revolution Medicines Inc | CANCER TREATMENT METHODS USING AN MTOR INHIBITOR |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4270297A (en) * | 1996-09-16 | 1998-04-02 | Du Pont Pharmaceuticals Company | Pyrazinones and triazinones and their derivatives thereof |
| PA8467401A1 (es) * | 1998-02-17 | 2000-09-29 | Pfizer Prod Inc | Procedimiento para tratar la insuficiencia cardiaca |
| IL139197A0 (en) * | 1999-10-29 | 2001-11-25 | Pfizer Prod Inc | Use of corticotropin releasing factor antagonists and related compositions |
| ATE307121T1 (de) * | 2000-02-16 | 2005-11-15 | Neurogen Corp | Substituierte arylpyrazine |
-
2003
- 2003-08-27 EP EP03751841A patent/EP1539736A1/en not_active Withdrawn
- 2003-08-27 US US10/649,299 patent/US20040116444A1/en not_active Abandoned
- 2003-08-27 AU AU2003269949A patent/AU2003269949A1/en not_active Abandoned
- 2003-08-27 BR BR0314139-0A patent/BR0314139A/pt not_active IP Right Cessation
- 2003-08-27 CA CA002494975A patent/CA2494975A1/en not_active Abandoned
- 2003-08-27 MX MXPA05002418A patent/MXPA05002418A/es not_active Application Discontinuation
- 2003-08-27 JP JP2004536018A patent/JP2006506350A/ja not_active Abandoned
- 2003-08-27 WO PCT/US2003/024805 patent/WO2004024719A1/en not_active Ceased
- 2003-09-02 AR ARP030103176A patent/AR041125A1/es unknown
- 2003-09-10 TW TW092125064A patent/TW200503717A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20040116444A1 (en) | 2004-06-17 |
| AR041125A1 (es) | 2005-05-04 |
| TW200503717A (en) | 2005-02-01 |
| MXPA05002418A (es) | 2005-05-27 |
| BR0314139A (pt) | 2005-07-12 |
| CA2494975A1 (en) | 2004-03-25 |
| WO2004024719A1 (en) | 2004-03-25 |
| JP2006506350A (ja) | 2006-02-23 |
| EP1539736A1 (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003224111A1 (en) | Substituted pyrazolo-pyrimidine-4-ones | |
| AP2005003198A0 (en) | Spiroindolinepiperidine derivatives. | |
| ZA200500170B (en) | Indole-3-sulphur derivatives. | |
| AU2002361992A1 (en) | 1,4-dihydro-1,4-diphenylpyridine derivatives | |
| AU2003211362A1 (en) | N-hydroxycarboxamide derivative | |
| WO2003072535A8 (en) | Substituted hydroxyethylamines | |
| AU2003257437A1 (en) | Novel 2,5-disubstituted pyrimidine derivatives | |
| AU2003238043A1 (en) | Substituted imidazotriazines | |
| AU2003245984A1 (en) | Hetero-cyclicaly substituted imidazotriazines | |
| AU2003264207A1 (en) | 1,4-substituted cyclohexane derivatives | |
| AU2003301968A1 (en) | 4-aminomethyl-1-aryl-cyclohexylamine derivatives | |
| AU2003299648A1 (en) | Substituted 4-phenyl-(1,3)-dioxanes | |
| AU2003247706A1 (en) | 6, 11-4-carbon bridged erythromycin derivatives | |
| AU2003294900A1 (en) | Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides | |
| AU2003278369A1 (en) | 3-cyano-quinoline derivatives | |
| AU2003296564A1 (en) | 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives | |
| AU2003222659A1 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
| AU2003212366A1 (en) | Substituted 4-aminocyclohexanols | |
| AU2003258598A1 (en) | Substituted 1,2,3,4-tetrahydroquinoline derivatives | |
| AU2003234131A1 (en) | 5-o-mycaminosyltylonide derivatives | |
| AU2002249639A1 (en) | Pyranocoumarin derivatives | |
| AU2003273398A1 (en) | Aroyl-piperidine derivatives | |
| AU2003238180A1 (en) | 2-naphtamide derivatives | |
| AU2003284704A1 (en) | Substituted 1h-pyridine-2-one derivatives | |
| AU2003288012A1 (en) | Isothiazolyl-benzoxazine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |